Cardlytics, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
The Vanguard Group has filed an amendment to its Schedule 13G, disclosing a 4.60% beneficial ownership stake in Cardlytics Inc. as of June 30, 2025.
NASDAQ
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, disclosing a 2.1% passive beneficial ownership stake in Cardlytics, Inc. as of June 30, 2025.